B. Vakrmanova

Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study

N. André, O. Hrusak, M. Devidas, 2021, The Lancet Oncology.

Blast clearance after one week of corticosteroids correlates with outcome and genetics but does not justify adding a residual disease time point in acute lymphoblastic leukemia treatment

E. Mejstrikova, O. Hrusak, E. Froňková, 2020, Leukemia & lymphoma.

DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch

T. Kalina, E. Mejstrikova, J. Stuchly, 2020, Haematologica.

International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.

E. Mejstrikova, O. Hrusak, M. Schrappe, 2018, Blood.

CD38: A target in relapsed/refractory acute lymphoblastic leukemia—Limitations in treatment and diagnostics

E. Mejstrikova, O. Hrusak, E. Froňková, 2022 .